Advertisement
Screener

AbCellera Biologics Inc. (ABCL) Pre-Tax Margin

AbCellera Biologics Inc. (ABCL) Pre-Tax Margin

  • 2026-06-30: Pre-Tax Margin -1455.93%.
  • 2026-03-31: Pre-Tax Margin -595.75%.
  • 2025-12-31: Pre-Tax Margin -43.47%.
  • 2025-09-30: Pre-Tax Margin -767.93%.

Complete source-backed pre-tax margin history.

Available history
2019-12-31 to 2026-06-30
Data captured

Historical Pre-Tax Margin

DatePre-Tax Margin
2026-06-30-1455.93%
2026-03-31-595.75%
2025-12-31-43.47%
2025-09-30-767.93%
2025-06-30-212.74%
2025-03-31-1251.10%
2024-12-31-927.31%
2024-09-30-962.53%
2024-06-30-658.02%
2024-03-31-429.45%
2023-12-31-529.49%
2023-09-30-595.18%
2023-06-30-377.92%
2023-03-31-394.91%
2022-12-31-145.80%
2022-09-3045.95%
2022-06-30-15.00%
2022-03-3172.91%
2021-12-3160.80%
2021-09-30-453.38%
2021-06-30-7.50%
2021-03-3179.65%
2020-12-3174.99%
2020-09-30-28.77%
2020-06-3059.70%
2020-03-31-44.94%

Annual Pre-Tax Margin

DatePre-Tax Margin
2025-12-31-236.39%
2024-12-31-695.02%
2023-12-31-457.67%
2022-12-3149.26%
2021-12-3158.41%
2020-12-3167.69%
2019-12-31-19.04%

Similar stocks

Stock NameCountryMarket CapPE Ratio
ACADIA PHARMACEUTICALS INC (ACAD)United States$3.823B11.45
Xenon Pharmaceuticals Inc. (XENE)$3.684B-14.27
Tango Therapeutics, Inc. (TNGX)United States$4.154B-42.53
Organon & Co. (OGN)United States$3.603B17.03
IDEAYA Biosciences, Inc. (IDYA)United States$3.540B-20.52
Indivior Pharmaceuticals, Inc. (INDV)$4.250B14.09
Viking Therapeutics, Inc. (VKTX)United States$4.287B-8.51
Amylyx Pharmaceuticals, Inc. (AMLX)United States$3.361B-13.15
Enliven Therapeutics, Inc. (ELVN)United States$3.307B-35.07
Arcutis Biotherapeutics, Inc. (ARQT)United States$3.303B115.47